Curriculum

New Frontiers in Basal Insulin: Weekly Dosing and Digital Tools

Break through therapeutic inertia in type 2 diabetes mellitus (T2DM). This engaging module explores barriers to basal insulin initiation, practical strategies to overcome them, and emerging innovations like once-weekly insulins. Gain actionable insights to optimize patient outcomes and enhance your T2DM care approach. Don’t miss this essential learning opportunity!

Loading... Begin
Measuring blood sugar

CME Information

1.00 AMA PRA Category 1 Credits™, 1.00 ABIM MOC or 1.23 AANP, 0.88 AANP Pharm

Release Date: 1/31/2025

Available for credit until 1/31/2026

Topics

Faculty

Learning Objectives

  • Review the current role and benefits of basal insulin in T2DM management
  • Identify barriers to insulin initiation and intensification as well as strategies to overcome these barriers
  • Examine the evidence on emerging once-weekly insulins
  • Discuss available evidence on insulin dosing apps and strategies to incorporate them into clinical care
 

Courses

1.00 CME/CE CREDIT

4 Courses

Faculty

Martin J. Abrahamson, MD, FACP

Associate Professor of Medicine, Harvard Medical School, Boston, MA

Read More
Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES

Endocrine Clinical Pharmacy Specialist, Department of Endocrinology, Diabetes & Metabolism, CGM Program Coordinator, Cleveland Clinic

Read More

Supported By

This activity is supported by an educational grant from Lilly.

Education Partner

Pri Med Institute